Cargando…
TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target
Pulmonary fibrosis (PF) is a chronic, progressive, fatal interstitial lung disease with limited available therapeutic strategies. We recently reported that the protein kinase glycogen synthase kinase-3β (GSK-3β) interacts with and inactivates the ubiquitin-editing enzyme A20 to suppress the degradat...
Autores principales: | Liu, Shanshan, Lv, Xiaoxi, Wei, Xupeng, Liu, Chang, Li, Qiao, Min, Jiali, Hua, Fang, Zhang, Xiaowei, Li, Ke, Li, Pingping, Xiao, Yang, Hu, Zhuowei, Cui, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546892/ https://www.ncbi.nlm.nih.gov/pubmed/34729304 http://dx.doi.org/10.1016/j.apsb.2021.06.017 |
Ejemplares similares
-
TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2
por: Lv, Xiaoxi, et al.
Publicado: (2023) -
1,25-Dihydroxyvitamin D3 protects obese rats from metabolic syndrome via promoting regulatory T cell-mediated resolution of inflammation
por: Jin, Wen, et al.
Publicado: (2018) -
The cell cycle inhibitor P21 promotes the development of pulmonary fibrosis by suppressing lung alveolar regeneration
por: Lv, Xiaoxi, et al.
Publicado: (2022) -
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target
por: Yu, Jiao-jiao, et al.
Publicado: (2020) -
TRIB3 Mediates Fibroblast Activation and Fibrosis though Interaction with ATF4 in IPF
por: Wang, Lan, et al.
Publicado: (2022)